Business Context and Reporting Period
Tenon Medical, Inc. (TNON), a Delaware corporation, filed this Form 8-K on July 20, 2023. The company is an emerging growth company with its principal executive offices in Los Gatos, California. The filing addresses a regulatory notice regarding the continued listing of its common stock and warrants on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a listing compliance issue.
Material Changes and Events
The material event reported is the receipt of a deficiency notice from Nasdaq on July 20, 2023. The notice states that the company's common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days between June 6, 2023, and July 19, 2023, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
- Compliance Period: The company has been granted an initial 180-day compliance period ending January 16, 2024, to regain compliance.
- Requirements: To regain compliance, the closing bid price must meet or exceed $1.00 per share for 10 consecutive trading days before the deadline.
- Contingencies: If compliance is not met by January 16, 2024, the company may be eligible for an additional 180-day period, provided it meets other listing standards (such as market value of publicly held shares) and notifies Nasdaq of its intent to cure the deficiency, potentially via a reverse stock split.
- Risks: Failure to regain compliance during any granted period will result in delisting. The company may appeal a delisting determination to a Nasdaq hearings panel.
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade under the symbol "TNON." Management is evaluating options to regain compliance, though there is no assurance of success.
Investor Verification Checklist
- Verify the current closing bid price of TNON to assess proximity to the $1.00 threshold.
- Monitor the company's stock price performance over the next 10 consecutive trading days to determine if the initial compliance requirement is met.
- Review future filings for announcements regarding a potential reverse stock split or other capital structure changes intended to address the bid price deficiency.
- Check for any subsequent Nasdaq communications regarding the extension of the compliance period or delisting proceedings.